Compugen Ltd.
CGEN
$2.24
$0.031.36%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -16.72% | 698.03% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -16.72% | 698.03% | |
| Cost of Revenue | -- | -- | 295.71% | 849.64% | |
| Gross Profit | -- | -- | -36.63% | 675.37% | |
| SG&A Expenses | -- | -- | 0.40% | 0.31% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -7.96% | 17.31% | |
| Operating Income | -- | -- | -14.62% | 130.65% | |
| Income Before Tax | -- | -- | 0.77% | 147.95% | |
| Income Tax Expenses | -- | -- | -49.59% | 61,372.73% | |
| Earnings from Continuing Operations | -- | -- | 24.12% | 105.07% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | 24.12% | 105.07% | |
| EBIT | -- | -- | -14.62% | 130.65% | |
| EBITDA | -- | -- | -15.18% | 132.48% | |
| EPS Basic | -- | -- | 26.40% | 105.34% | |
| Normalized Basic EPS | -- | -- | -209.43% | 230.59% | |
| EPS Diluted | -- | -- | 25.61% | 105.33% | |
| Normalized Diluted EPS | -- | -- | -209.43% | 230.59% | |
| Average Basic Shares Outstanding | -- | -- | 2.16% | 2.36% | |
| Average Diluted Shares Outstanding | -- | -- | 2.16% | 2.36% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |